戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  or without cerebrovascular disease, defined neuropathologically.
2 s have been the most commonly affected cells neuropathologically.
3 our with Parkinson's disease, both confirmed neuropathologically.
4 gnosis of multiple system atrophy, confirmed neuropathologically.
5 d those who subsequently died were evaluated neuropathologically.
6 multiple system atrophy, both clinically and neuropathologically.
7 grel dogs weighing 23 to 30 kg and validated neuropathologically.
8  were highly abundant and were found only in neuropathologically affected areas of ALS patients but n
9 cts with clinical diagnosis of MSA confirmed neuropathologically and five age-matched controls.
10 renia (N=26) were compared with those from a neuropathologically and neuropsychiatrically normal elde
11 ltiple system atrophy (MSA) cases, confirmed neuropathologically, and eight age-matched controls.
12  identified in the tissue, blindly described neuropathologically, and subsequently divided into ische
13 easured functionally as dementia severity or neuropathologically as increased neuritic plaque and neu
14 ases, which were confirmed biochemically and neuropathologically as variably protease-sensitive prion
15 of 1110 patients, all of whom were evaluated neuropathologically at the University of Kentucky.
16                          Among patients with neuropathologically based diagnoses, PET identified pati
17  and Alzheimer's diseases, are characterized neuropathologically by accumulation of misfolded protein
18 progressive myoclonus epilepsy characterized neuropathologically by aggregates of abnormally structur
19  Both human and murine NPC are characterized neuropathologically by ballooned neurons distended with
20 order characterized clinically by ataxia and neuropathologically by cerebellar atrophy and granule ce
21              Pick's disease is characterized neuropathologically by distinct tau-immunoreactive intra
22                 The disease is characterized neuropathologically by frontal and temporal lobar atroph
23  features, as well as cerebellar ataxia, and neuropathologically by neuronal loss, gliosis, and iron
24      Alzheimer disease (AD) is characterized neuropathologically by synaptic disruption, neuronal los
25      Alzheimer disease (AD) is characterized neuropathologically by the presence of amyloid beta-pept
26 odegenerative disorder that is characterized neuropathologically by the presence of neuropil aggregat
27  causes and disease symptoms, and are linked neuropathologically by the RNA binding protein TDP-43 (T
28 jor constituent of ubiquitin inclusions that neuropathologically characterize ALS.
29 n hippocampal subfields in 95 clinically and neuropathologically characterized human cases of DLB, fi
30 prefrontal cortex of antemortem-assessed and neuropathologically characterized schizophrenic and comp
31  From these studies, it is clear that MCI is neuropathologically complex and cannot be understood wit
32 eresting that, in four of four patients with neuropathologically confirmed acute hypoxic changes, we
33  disease in the clinically characterized and neuropathologically confirmed AD cases and controls.
34 nd axons in optic nerve cross-sections of 14 neuropathologically confirmed AD patients.
35 ivating polypeptide (PACAP) in patients with neuropathologically confirmed Alzheimer dementia.
36               Among the 14 sisters who died, neuropathologically confirmed Alzheimer's disease was pr
37 e United Kingdom, of which 33 cases had been neuropathologically confirmed and 2 classified as probab
38  Alzheimer's disease) prospectively studied, neuropathologically confirmed cases.
39 and spinal cord samples originating from 137 neuropathologically confirmed control individuals to stu
40 fidence interval: 1.06-1.20) and presence of neuropathologically confirmed degenerative changes (that
41 d with a novel PRNP mutation associated with neuropathologically confirmed Gerstmann-Straussler-Schei
42 Center (1985-2015) and 1115 individuals with neuropathologically confirmed LOAD were included from th
43 ts (8 men, 3 women, age 64 +/- 3 years) with neuropathologically confirmed MSA and 11 control subject
44                            Fourteen cases of neuropathologically confirmed multiple sclerosis (8 fema
45  in human post-mortem cerebellar tissue from neuropathologically confirmed PD cases and neurologicall
46 ently examined that consisted of 67 cases of neuropathologically confirmed sCJD (33 female, 34 male;
47  analyzed 108 CSF samples from patients with neuropathologically confirmed sCJD or from control patie
48 sues obtained at necropsy from patients with neuropathologically confirmed variant CJD, but not from
49  tissues at necropsy from four patients with neuropathologically confirmed vCJD and from individuals
50 cribe a family (DUK1684) with clinically and neuropathologically confirmed, autosomal dominant, non-A
51 on markers from a unique cohort of over 1600 neuropathologically defined AD cases and controls (1019
52 e units [95% CI, -1.52 to -0.02]), and lower neuropathologically defined Alzheimer disease (beta = -0
53 obulin gene is a risk factor associated with neuropathologically defined Alzheimer's disease in our p
54 enerative diseases termed synucleinopathies, neuropathologically defined by inclusions containing agg
55 lpha2-macroglobulin gene was associated with neuropathologically defined diagnosis of Alzheimer's dis
56                        In patients who died, neuropathologically determined neuritic plaque levels we
57 uantified in temporalis muscles and brain of neuropathologically diagnosed Alzheimer disease (AD) and
58 [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; media
59 rtex, and sensory cortex from clinically and neuropathologically diagnosed sporadic ALS cases and age
60 f cognitive deficits occur in AD and several neuropathologically distinct age-associated neurodegener
61 f FTD pathology, suggesting that bvFTD-SP is neuropathologically distinct from other forms of FTD.
62 riends or family members of individuals with neuropathologically documented CTE.
63                                  In the nine neuropathologically examined cases, the presence of hist
64                                              Neuropathologically, GRN(-/+) were indistinguishable fro
65                                              Neuropathologically, HDDD2 represents a familial frontot
66 ofile of 788 brain samples obtained from 101 neuropathologically healthy individuals (10 distinct bra
67 RNA expression profile of brain samples from neuropathologically healthy individuals, showed that KCT
68 ty, suggesting ischaemic demyelination, seen neuropathologically in SVD, may be an important predicto
69 istory of parkinsonism or dementia confirmed neuropathologically, including PSP (n = 24), corticobasa
70  received immunisation and who were examined neuropathologically, mean Abeta load was lower than in a
71                                           In neuropathologically normal (control) brains (n=3), serot
72 n applied to an array-based dataset from 150 neuropathologically normal adult human brains, our metho
73 ous other neurodegenerative diseases, and 45 neuropathologically normal cases.
74 g and expression analysis on a series of 193 neuropathologically normal human brain samples using the
75 rebellum and frontal cortex tissues from 438 neuropathologically normal individuals.
76 rain transcriptome and genome in a series of neuropathologically normal postmortem samples.
77 one comprised of four brain regions from 150 neuropathologically normal samples and another comprised
78 ther comprised of ten brain regions from 134 neuropathologically normal samples, and show that by usi
79 in males, both clinically (age of death) and neuropathologically (number of inclusions).
80                           In a case examined neuropathologically, parenchymal T-lymphocyte infiltrati
81 under-reported lesions subsequently analysed neuropathologically, particularly those arising within t
82                                              Neuropathologically, progressive nerve cell loss, gliosi
83 e also performed the analysis including only neuropathologically proven DLB cases (667 cases).
84 included a chronic spinocerebellar syndrome, neuropathologically proven Leigh syndrome, and sudden de
85                                              Neuropathologically the disease is characterized by exte
86                                              Neuropathologically, the disease is characterized by pre
87                                              Neuropathologically, the distribution of neuropil aggreg
88                                              Neuropathologically, the improvement in lifespan and mot
89                                              Neuropathologically, the severe phenotype of SCA17 rats
90 cle events, we investigated the brains of 12 neuropathologically verified cases of Alzheimer's diseas
91 at provide a reliable and valid indicator of neuropathologically verified CTE.
92                    In epsilon4 carriers from neuropathologically verified discovery, neuropathologica
93 from neuropathologically verified discovery, neuropathologically verified replication, and clinically
94                  SN depigmentation, detected neuropathologically, was correlated with clinical parame

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。